{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:26:39Z","timestamp":1790018799134,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472209"],"award-info":[{"award-number":["81472209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["K2015311201501"],"award-info":[{"award-number":["K2015311201501"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00432-020-03157-2","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T09:02:46Z","timestamp":1582362166000},"page":"861-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer"],"prefix":"10.1007","volume":"146","author":[{"given":"Tahir","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sakhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon Rashid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2013-4500","authenticated-orcid":false,"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"3157_CR1","unstructured":"Andrews P, Howell S (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells (Cold Spring Harbor, NY: 1989) 2:35\u201343."},{"key":"3157_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","volume":"395","author":"S Bates","year":"1998","unstructured":"Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH (1998) p14 ARF links the tumour suppressors RB and p53. Nature 395:124","journal-title":"Nature"},{"key":"3157_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.18632\/oncotarget.805","volume":"4","author":"WN Brennen","year":"2013","unstructured":"Brennen WN, Chen S, Denmeade SR, Isaacs JT (2013) Quantification of mesenchymal stem cells (MSCs) at sites of human prostate cancer. Oncotarget 4:106","journal-title":"Oncotarget"},{"key":"3157_CR4","doi-asserted-by":"publisher","first-page":"46710","DOI":"10.18632\/oncotarget.17362","volume":"8","author":"WN Brennen","year":"2017","unstructured":"Brennen WN et al (2017) Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. Oncotarget 8:46710","journal-title":"Oncotarget"},{"key":"3157_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biopha.2017.09.066","volume":"97","author":"S Chen","year":"2018","unstructured":"Chen S et al (2018) Aloperine induces apoptosis and inhibits invasion in MG-63 and U2OS human osteosarcoma cells. Biomed Pharmacother 97:45\u201352","journal-title":"Biomed Pharmacother"},{"key":"3157_CR6","first-page":"61","volume":"1","author":"T Chou","year":"1991","unstructured":"Chou T (1991) The median-effect principle and the combination index for quantitation of synergism and antagonism. Synerg Antagonism Chemother 1:61\u2013102","journal-title":"Synerg Antagonism Chemother"},{"key":"3157_CR7","volume-title":"A computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values CompuSyn for Drug Combinations: PC Software and User\u2019s Guide; ComboSyn: Paramus","author":"T Chou","year":"2005","unstructured":"Chou T, Martin N (2005) A computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values CompuSyn for Drug Combinations: PC Software and User\u2019s Guide; ComboSyn: Paramus. NJ, USA"},{"key":"3157_CR8","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1101\/gad.12.15.2434","volume":"12","author":"E de Stanchina","year":"1998","unstructured":"de Stanchina E et al (1998) E1A signaling to p53 involves the p19ARFtumor suppressor. Genes Dev 12:2434\u20132442","journal-title":"Genes Dev"},{"key":"3157_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","volume":"76","author":"V Duli\u0107","year":"1994","unstructured":"Duli\u0107 V et al (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013\u20131023","journal-title":"Cell"},{"key":"3157_CR10","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2012","unstructured":"Ferlay J et al (2012) (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"key":"3157_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/bjc.1993.221","volume":"67","author":"D Gately","year":"1993","unstructured":"Gately D, Howell S (1993) Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67:1171","journal-title":"Br J Cancer"},{"key":"3157_CR12","first-page":"4855","volume":"54","author":"M Greenblatt","year":"1994","unstructured":"Greenblatt M, Bennett WP, Hollstein M, Harris C (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855\u20134878","journal-title":"Cancer Res"},{"key":"3157_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553:446","journal-title":"Nature"},{"key":"3157_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49\u201353","journal-title":"Science"},{"key":"3157_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/emboj\/18.1.22","volume":"18","author":"R Honda","year":"1999","unstructured":"Honda R, Yasuda H (1999) Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18:22\u201327","journal-title":"EMBO J"},{"key":"3157_CR16","doi-asserted-by":"publisher","first-page":"e0168989","DOI":"10.1371\/journal.pone.0168989","volume":"12","author":"W-S Huang","year":"2017","unstructured":"Huang W-S et al (2017) CIL-102-induced cell cycle arrest and apoptosis in colorectal cancer cells via upregulation of p21 and GADD45. PLoS ONE 12:e0168989","journal-title":"PLoS ONE"},{"key":"3157_CR17","first-page":"3646","volume":"63","author":"Y Huang","year":"2003","unstructured":"Huang Y, Tyler T, Saadatmandi N, Lee C, Borgstrom P, Gjerset RA (2003) Enhanced tumor suppression by a p14ARF\/p53 bicistronic adenovirus through increased p53 protein translation and stability. Cancer Res 63:3646\u20133653","journal-title":"Cancer Res"},{"key":"3157_CR18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","volume":"378","author":"A Jemal","year":"2018","unstructured":"Jemal A et al (2018) Higher lung cancer incidence in young women than young men in the United States. N Engl J Med 378:1999\u20132009","journal-title":"N Engl J Med"},{"key":"3157_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/biot.201400390","volume":"10","author":"H Kallel","year":"2015","unstructured":"Kallel H, Kamen AA (2015) Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials. Biotechnol J 10:741\u2013747","journal-title":"Biotechnol J"},{"key":"3157_CR20","first-page":"585","volume":"16","author":"K Kannan","year":"2000","unstructured":"Kannan K et al (2000) The p16INK4alpha\/p19ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas. Int J Oncol 16:585\u2013675","journal-title":"Int J Oncol"},{"key":"3157_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573","journal-title":"Nat Rev Cancer"},{"key":"3157_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/1940-6207.CAPR-13-0288","volume":"7","author":"MS Kim","year":"2014","unstructured":"Kim MS et al (2014) Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev Res 7:236\u2013245","journal-title":"Cancer Prev Res"},{"key":"3157_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/ijms19010312","volume":"19","author":"Y-R Lee","year":"2018","unstructured":"Lee Y-R, Chen S-H, Lin C-Y, Chao W-Y, Lim Y-P, Yu H-I, Lu C-H (2018) Vitro antitumor activity of aloperine on human thyroid cancer cells through caspase-dependent apoptosis. Int J Mol Sci 19:312","journal-title":"Int J Mol Sci"},{"key":"3157_CR24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.lfs.2012.09.021","volume":"91","author":"L Liang","year":"2012","unstructured":"Liang L, Wang X-Y, Zhang X-H, Ji B, Yan H-C, Deng H-Z, Wu X-R (2012) Sophoridine exerts an anti-colorectal carcinoma effect through apoptosis induction in vitro and in vivo. Life Sci 91:1295\u20131303","journal-title":"Life Sci"},{"key":"3157_CR25","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.2147\/OTT.S165262","volume":"11","author":"Z Ling","year":"2018","unstructured":"Ling Z et al (2018) Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo. OncoTargets Ther 11:2735","journal-title":"OncoTargets Ther"},{"key":"3157_CR26","doi-asserted-by":"publisher","first-page":"152843","DOI":"10.1016\/j.phymed.2019.152843","volume":"61","author":"J-S Liu","year":"2019","unstructured":"Liu J-S et al (2019) Aloperine induces apoptosis and G2\/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K\/Akt signaling pathway. Phytomedicine 61:152843","journal-title":"Phytomedicine"},{"key":"3157_CR27","unstructured":"Maher A, Miake-Lye I, Beroes J, Shekelle P (2012) Treatment of metastatic non-small cell lung cancer: a systematic review of comparative effectiveness and cost-effectiveness"},{"key":"3157_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271\u2013289","journal-title":"CA Cancer J Clin"},{"key":"3157_CR29","doi-asserted-by":"crossref","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. In: Mayo clinic proceedings, 2008, vol 5. Elsevier, pp 584\u2013594","DOI":"10.1016\/S0025-6196(11)60735-0"},{"key":"3157_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13287-019-1268-z","volume":"10","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Sakhawat A, Khan AA, Ma L, Gjerset RA, Huang Y (2019) Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer. Stem Cell Res Ther 10:190","journal-title":"Stem Cell Res Ther"},{"key":"3157_CR31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1158\/0008-5472.CAN-10-2349","volume":"71","author":"M Muthana","year":"2011","unstructured":"Muthana M et al (2011) Use of macrophages to target therapeutic adenovirus to human prostate tumors. Can Res 71:1805\u20131815","journal-title":"Can Res"},{"key":"3157_CR32","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1517\/14712598.2010.531257","volume":"10","author":"TJ Myers","year":"2010","unstructured":"Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, Spagnoli A (2010) Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther 10:1663\u20131679","journal-title":"Expert Opin Biol Ther"},{"key":"3157_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/25870","volume":"395","author":"I Palmero","year":"1998","unstructured":"Palmero I, Pantoja C, Serrano M (1998) p19 ARF links the tumour suppressor p53 to Ras. Nature 395:125","journal-title":"Nature"},{"key":"3157_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0002-9440(10)65071-7","volume":"156","author":"M Pinyol","year":"2000","unstructured":"Pinyol M et al (2000) INK4a\/ARFLocus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am J Pathol 156:1987\u20131996","journal-title":"Am J Pathol"},{"key":"3157_CR35","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0955-0674(97)80076-2","volume":"9","author":"MD Planas-Silva","year":"1997","unstructured":"Planas-Silva MD, Weinberg RA (1997) The restriction point and control of cell proliferation. Curr Opin Cell Biol 9:768\u2013772","journal-title":"Curr Opin Cell Biol"},{"key":"3157_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.13-S1-5","volume":"13","author":"S Ramalingam","year":"2008","unstructured":"Ramalingam S, Belani C (2008) Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 13:5\u201313","journal-title":"Oncologist"},{"key":"3157_CR37","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.7150\/jca.18371","volume":"8","author":"A Sakhawat","year":"2017","unstructured":"Sakhawat A, Liu Y, Ling Ma TM, Wang S, Zhang L, Cong X, Huang Y (2017) Upregulation of Coxsackie adenovirus receptor sensitizes cisplatin-resistant lung cancer cells to CRAd-induced inhibition. J Cancer 8:1425","journal-title":"J Cancer"},{"key":"3157_CR38","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1016\/j.biomaterials.2010.03.006","volume":"31","author":"D Sarkar","year":"2010","unstructured":"Sarkar D, Vemula PK, Zhao W, Gupta A, Karnik R, Karp JM (2010) Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials 31:5266\u20135274","journal-title":"Biomaterials"},{"key":"3157_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/sctm.18-0230","volume":"8","author":"MT Schweizer","year":"2019","unstructured":"Schweizer MT et al (2019) A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer. Stem Cells Trans Med 8:441\u2013449","journal-title":"Stem Cells Trans Med"},{"key":"3157_CR40","doi-asserted-by":"crossref","unstructured":"Serakinci N, Cagsin H (2019a) Programming hMSCs into potential genetic therapy in cancer critical reviews\u2122 in eukaryotic gene expression 29","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019030483"},{"key":"3157_CR41","doi-asserted-by":"crossref","unstructured":"Serakinci N, Cagsin H (2019b) Turning stem cells homing potential into cancer specific drug delivery machines. Ann Transl Med 7","DOI":"10.21037\/atm.2019.06.30"},{"key":"3157_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12935-016-0377-3","volume":"17","author":"X-l Song","year":"2017","unstructured":"Song X-l et al (2017) Casticin induces apoptosis and G0\/G1 cell cycle arrest in gallbladder cancer cells. Cancer Cell Int 17:9","journal-title":"Cancer Cell Int"},{"key":"3157_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1164\/rccm.200202-070SO","volume":"166","author":"SG Spiro","year":"2002","unstructured":"Spiro SG, Porter JC (2002) Lung cancer\u2014where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 166:1166\u20131196","journal-title":"Am J Respir Crit Care Med"},{"key":"3157_CR44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrclinonc.2015.90","volume":"12","author":"A Thomas","year":"2015","unstructured":"Thomas A, Liu SV, Subramaniam DS, Giaccone G (2015) Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol 12:511","journal-title":"Nat Rev Clin Oncol"},{"key":"3157_CR45","first-page":"3699","volume":"18","author":"D Tian","year":"2018","unstructured":"Tian D, Li Y, Li X, Tian Z (2018) Aloperine inhibits proliferation, migration and invasion and induces apoptosis by blocking the Ras signaling pathway in human breast cancer cells. Mol Med Rep 18:3699\u20133710","journal-title":"Mol Med Rep"},{"key":"3157_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"3157_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21335","volume":"66","author":"LA Torre","year":"2016","unstructured":"Torre LA, Sauer AMG, Chen MS Jr, Kagawa-Singer M, Jemal A (2016) Siegel RL (2016) Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders converging incidence in males and females CA. Cancer J Clin 66:182\u2013202","journal-title":"Cancer J Clin"},{"key":"3157_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpba.2012.04.024","volume":"67","author":"H Wang","year":"2012","unstructured":"Wang H, Guo S, Qian D, Qian Y, Duan JA (2012) Comparative analysis of quinolizidine alkaloids from different parts of Sophora alopecuroides seeds by UPLC\u2013MS\/MS. J Pharmaceut Biomed Anal 67:16\u201321","journal-title":"J Pharmaceut Biomed Anal"},{"key":"3157_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13045-015-0120-x","volume":"8","author":"H Wang","year":"2015","unstructured":"Wang H et al (2015) Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms. J Hematol Oncol 8:26","journal-title":"J Hematol Oncol"},{"key":"3157_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/path.3022","volume":"226","author":"GH Williams","year":"2012","unstructured":"Williams GH, Stoeber K (2012) The cell cycle and cancer. J Pathol 226:352\u2013364","journal-title":"J Pathol"},{"key":"3157_CR51","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","volume":"7","author":"X Wu","year":"1993","unstructured":"Wu X, Bayle JH, Olson D, Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126\u20131132","journal-title":"Genes Dev"},{"key":"3157_CR52","doi-asserted-by":"crossref","unstructured":"Xu Z et al. (2017) Reducing autophagy and inducing G1 phase arrest by aloperine enhances radio-sensitivity in lung cancer cells. Oncol Rep","DOI":"10.3892\/or.2017.5732"},{"key":"3157_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2009.12.007","volume":"629","author":"X-Y Yuan","year":"2010","unstructured":"Yuan X-Y, Liu W, Zhang P, Wang R-Y, Guo J-Y (2010) Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB\/c mice. Eur J Pharmacol 629:147\u2013152","journal-title":"Eur J Pharmacol"},{"key":"3157_CR54","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0145-2126(00)00145-4","volume":"25","author":"L Zhang","year":"2001","unstructured":"Zhang L et al (2001) Effects of matrine on proliferation and differentiation in K-562 cells. Leukemia Res 25:793\u2013800","journal-title":"Leukemia Res"},{"key":"3157_CR55","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ptr.3657","volume":"26","author":"Z Zhang","year":"2012","unstructured":"Zhang Z et al (2012) Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res 26:932\u2013937","journal-title":"Phytother Res"},{"key":"3157_CR56","first-page":"328","volume":"20","author":"L Zhang","year":"1998","unstructured":"Zhang L, Jiang J, Tan R (1998) Effects of matrine on telomerase activity and cell cycle in K562 cell. Chin J Oncol 20:328\u2013329","journal-title":"Chin J Oncol"},{"key":"3157_CR57","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3892\/ijmm.2014.1718","volume":"33","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zheng Y, Deng H, Liang L, Peng J (2014) Aloperine induces G2\/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells. Int J Mol Med 33:1613\u20131620","journal-title":"Int J Mol Med"},{"key":"3157_CR58","first-page":"360","volume":"10","author":"C Zhou","year":"1989","unstructured":"Zhou C, Gao H, Sun X, Shi H, Liu W, Yuan H, Wang Z (1989) Anti-inflammatory and anti-allergic action of aloperine. Acta Pharmacol Sin 10:360\u2013365","journal-title":"Acta Pharmacol Sin"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T13:10:43Z","timestamp":1650201043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03157-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study was approved by ethical committee of Beijing University of Technology (approval number IRB-1507).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}